Impax Asset Management Group Portfolio holdings
AUM
$17.4B
1-Year Return
13.12%
This Quarter Return
+12.8%
1 Year Return
+13.12%
3 Year Return
+65.42%
5 Year Return
+126.12%
10 Year Return
–
AUM
$24.9B
AUM Growth
+$2.53B
(+11%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
28.38%
Holding
422
New
27
Increased
128
Reduced
170
Closed
56
Top Buys
| 1 |
Veralto
VLTO
|
$348M |
| 2 |
MSCI
MSCI
|
$295M |
| 3 |
Marsh & McLennan
MMC
|
$262M |
| 4 |
Steris
STE
|
$171M |
| 5 |
Carrier Global
CARR
|
$61.5M |
Top Sells
| 1 |
Trimble
TRMB
|
$282M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$193M |
| 3 |
Rockwell Automation
ROK
|
$140M |
| 4 |
Equinix
EQIX
|
$115M |
| 5 |
United Rentals
URI
|
$80M |
Sector Composition
| 1 | Industrials | 31.42% |
| 2 | Technology | 22.54% |
| 3 | Healthcare | 14.97% |
| 4 | Financials | 8.91% |
| 5 | Materials | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Middleby
MIDD
$7.32B
| $24.3M | 0.1% |
165,184
-18,434
| -10% | -$2.71M |
|
127
Core & Main
CNM
$12.7B
| $21.9M | 0.09% |
541,200
-159,286
| -23% | -$6.44M |
|
|
AAMI
128
Acadian Asset Management Inc.
AAMI
$1.53B
| $20.1M | 0.08% |
1,048,818
+100,000
| +11% | +$1.92M |
|
129
Eli Lilly
LLY
$652B
| $17.6M | 0.07% |
30,268
+1,560
| +5% | +$909K |
|
130
Onto Innovation
ONTO
$5.1B
| $16.4M | 0.07% |
107,057
-18,000
| -14% | -$2.75M |
|
131
Intuit
INTU
$188B
| $16.3M | 0.07% |
26,137
+17,925
| +218% | +$11.2M |
|
132
Health Catalyst
HCAT
$238M
| $16.2M | 0.07% |
1,754,475
+600,000
| +52% | +$5.56M |
|
|
WRK
133
DELISTED
WestRock Company
WRK
| $15.7M | 0.06% |
377,081
-98,041
| -21% | -$4.07M |
|
134
Ciena
CIEN
$16.5B
| $15.6M | 0.06% |
346,064
+63,000
| +22% | +$2.84M |
|
135
Bath & Body Works
BBWI
$6.06B
| $15.4M | 0.06% |
356,910
+268,913
| +306% | +$11.6M |
|
|
AXNX
136
DELISTED
Axonics, Inc. Common Stock
AXNX
| $15.2M | 0.06% |
244,525
+30,000
| +14% | +$1.87M |
|
137
Huron Consulting
HURN
$2.44B
| $14.8M | 0.06% |
144,000
| – | – |
|
138
Coca-Cola
KO
$292B
| $14.8M | 0.06% |
250,919
-519
| -0.2% | -$30.6K |
|
139
Ligand Pharmaceuticals
LGND
$3.25B
| $14.7M | 0.06% |
205,208
+20,888
| +11% | +$1.49M |
|
140
Neurocrine Biosciences
NBIX
$14.3B
| $14.5M | 0.06% |
110,000
-25,000
| -19% | -$3.29M |
|
141
Citigroup
C
$176B
| $14.2M | 0.06% |
275,535
-19,205
| -7% | -$988K |
|
142
Starbucks
SBUX
$97.1B
| $14M | 0.06% |
145,497
+8,950
| +7% | +$859K |
|
143
Zoetis
ZTS
$67.9B
| $13.9M | 0.06% |
70,522
+33,678
| +91% | +$6.65M |
|
144
Celanese
CE
$5.34B
| $13.8M | 0.06% |
89,067
-5,770
| -6% | -$896K |
|
145
Workiva
WK
$4.48B
| $13.8M | 0.06% |
136,086
| – | – |
|
146
lululemon athletica
LULU
$19.9B
| $13.7M | 0.05% |
26,737
-4,057
| -13% | -$2.07M |
|
147
US Foods
USFD
$17.5B
| $13.6M | 0.05% |
300,000
+60,000
| +25% | +$2.72M |
|
148
Johnson & Johnson
JNJ
$430B
| $13.6M | 0.05% |
86,904
+6,209
| +8% | +$973K |
|
149
Edison International
EIX
$21B
| $13.4M | 0.05% |
187,538
-47,189
| -20% | -$3.37M |
|
|
150
Equinix
EQIX
$75.7B
| $13.4M | 0.05% |
16,593
-142,790
| -90% | -$115M |
|